HCA (HCA) CEO Samuel Hazen exercises 84,360 rights, gets new 55,846 grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HCA Healthcare CEO Samuel N. Hazen reported several equity compensation moves. On January 29, 2026, he received 55,846 stock appreciation rights with an exercise price of $482.53 per share, which vest in four equal annual installments beginning on January 29, 2027.
On January 30, 2026, Hazen exercised 84,360 stock appreciation rights, acquiring 84,360 shares of common stock at $81.96 per share. To cover tax obligations, 41,483 shares were surrendered at a value of $488.27 per share, leaving 75,153 shares of common stock held directly. He also reports additional indirect ownership through several trusts and an LP.
Positive
- None.
Negative
- None.
Insider Trade Summary
84,360 shares exercised/converted
Mixed
10 txns
Insider
HAZEN SAMUEL N
Role
CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Appreciation Right | 84,360 | $0.00 | -- |
| Exercise | Common Stock | 84,360 | $81.96 | $6.91M |
| Tax Withholding | Common Stock | 41,483 | $488.27 | $20.25M |
| Grant/Award | Stock Appreciation Right | 55,846 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Appreciation Right — 0 shares (Direct);
Common Stock — 116,636 shares (Direct);
Common Stock — 14,979 shares (Indirect, By HD Trust)
Footnotes (1)
- The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
FAQ
What insider transactions did HCA (HCA) CEO Samuel Hazen report?
Samuel N. Hazen reported a grant of 55,846 stock appreciation rights and the exercise of 84,360 rights into common stock. He also reported tax share withholding of 41,483 shares and now holds 75,153 shares directly, plus additional indirect holdings through trusts and an LP.
What stock appreciation rights were granted to HCA (HCA) CEO Samuel Hazen?
Samuel N. Hazen was granted 55,846 stock appreciation rights with an exercise price of $482.53 per share on January 29, 2026. These rights vest in four equal annual installments beginning January 29, 2027, providing potential future equity-linked compensation tied to HCA’s share price.
What happened when HCA (HCA) CEO Samuel Hazen exercised stock appreciation rights?
On January 30, 2026, Hazen exercised 84,360 stock appreciation rights, receiving 84,360 HCA common shares at $81.96 per share. To satisfy tax obligations, 41,483 of those shares were surrendered at a value of $488.27 per share, reducing his net direct holdings.
Does HCA (HCA) CEO Samuel Hazen report indirect ownership of company stock?
Yes. In addition to directly held shares, Hazen reports indirect ownership of HCA common stock through multiple entities, including HD Trust, 2023 GST Trust, 2023 Trust, 2024 GRAT, 2025 GRAT, and an LP, each holding separate blocks of shares on the Form 4.
When do Samuel Hazen’s newly granted HCA (HCA) stock appreciation rights vest?
The newly granted 55,846 stock appreciation rights begin vesting on January 29, 2027. According to the disclosure, they vest in four equal annual installments starting on that date, creating a multi-year vesting schedule tied to continued service and performance.